Farms.com Home   Farm Equipment News

Soft Commodity Prices Might Mean Slower Equipment Sales

There have been some challenges for farm equipment sales over the last couple of years, according to the CEO of the Western Equipment Dealers Association.
 
John Schmeiser says there was an incredible run of equipment sales from 2007 to 2014, and a lot of customers have re-invested in their machinery.
 
"At this point in time, because we've seen some softening in the commodity prices, they don't have to make that reinvestment," he says, "but having said that, in areas where there are lentils being grown — where the commodity price is still fairly strong — we are seeing a lot of sales activity. And what's really promising for us is we're still seeing a lot of quoting on deals."
 
On the manufacturing side, Schmeiser says they are seeing more new products rolling out to meet consumer demands for more production and better technology.
 
Source : Portageonline

Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.